Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
Add more filters










Publication year range
1.
Biomed Phys Eng Express ; 9(6)2023 10 02.
Article in English | MEDLINE | ID: mdl-37725948

ABSTRACT

Sertoli cells are essential for the male reproduction system as they provide morphological support and nutrients for germ cells to guarantee ongoing spermatogenesis. The aim of this work was to predict the electrical properties at the plasma membrane that trigger Sertoli cell rapid responses by involving ionic channels. The rapid responses of Sertoli cells in culture were monitored using patch clamp electrical measurement and compared to data obtained using pharmacological tools (from intact seminiferous tubules). A mathematical model was used to define the roles of potassium channels and the ATP-dependent Na+/K+pump in these responses. Mathematical data verification was also performed to determine the resting and hormonal stimulated membrane potentials of Sertoli cells in the intact seminiferous tubules and of Sertoli cells in culture (patch clamp measurements). The prediction of these data based on mathematical modeling demonstrated, for the first time, the involvement of potassium channels and the activation of Na+/K+pump in the hyperpolarization of Sertoli cells and their consequent rapid responses. Moreover, the mathematical analysis showing the involvement of ionic balance in the rapid responses of these cells to hormones, such as follicle-stimulating hormone, is consistent with previous reports obtained using pharmacological techniques in Sertoli cells. Thus, the validation of such data is reliable and represents a first step in the proposition for a mathematical model to predict rapid responses of Sertoli cells to hormonal stimuli.


Subject(s)
Sertoli Cells , Signal Transduction , Male , Humans , Sertoli Cells/metabolism , Membrane Potentials , Cell Membrane/metabolism , Potassium Channels/metabolism
2.
Invest New Drugs ; 38(3): 785-799, 2020 06.
Article in English | MEDLINE | ID: mdl-31257554

ABSTRACT

BackgroundWe investigated the role of reactive oxygen species (ROS) in the anticancer mechanism of N-benzyl-2-nitro-1-imidazole-acetamide (BZN), a drug used in Chagas' disease treatment. MethodsBALB/c mice, inoculated with Ehrlich ascites carcinoma (EAC), were treated with BZN or BZN + Nacylcysteine (NAC) or NAC for 9 days. Subsequently, the inhibition of tumor growth and angiogenesis as well as animal survival were evaluated. Apoptosis and the cell cycle were evaluated using fluorescence microscopy and flow cytometry, while oxidative stress was evaluated by measuring TBARS content, DNA damage, calcium influx and ROS generation and antioxidant defenses (CAT, SOD, GPx, GST and GR). Immunoblotting was used to evaluate key death and cell cycle proteins. Results BZN treatment inhibited tumor progression (79%), angiogenesis (2.8-fold) and increased animal survival (29%). Moreover, BZN increased ROS levels (42%), calcium influx (55%), TBARS contents (1.9-fold), SOD (4.4-fold), GPx (17.5-fold) and GST (3-fold) activities and GSH depletion (2.5-fold) also caused DNA fragmentation (7.6-fold), increased cleaved PARP and promoted the trapping of cells in the G1 phase, as corroborated by the reduction in cyclin A and increased CDK2 protein levels. In silico DNA and molecular dynamic simulations showed H-bonds and hydrophobic interactions that were confirmed by circular dichroism. Increased apoptosis (232%), induced by treatment with BZN, was demonstrated by apoptotic cell staining and p53 level. Conclusion The current findings indicate that BZN acts as a tumor growth inhibitor and anti-angiogenic agent by ROS overgeneration, which interact with DNA causing damage and triggering apoptosis.


Subject(s)
Acetamides/pharmacology , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Imidazoles/pharmacology , Neoplasms/drug therapy , Neoplasms/metabolism , Reactive Oxygen Species/metabolism , Animals , Antioxidants/metabolism , Cell Cycle/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , DNA Damage/drug effects , Male , Mice , Mice, Inbred BALB C , Oxidative Stress/drug effects
3.
J Cell Physiol ; 234(1): 509-520, 2018 01.
Article in English | MEDLINE | ID: mdl-29968920

ABSTRACT

New compounds with promising antidiabetic activity were synthesized. For the first time, a portion of the glibenclamide molecule was bound to a part of the core structure of thiazolidinedione to evaluate insulin secretagogue activity. Following studies in our laboratory, 4-{2-[2-(3,4-dichlorophenyl)-4-oxo-1,3-thiazolidin-3-yl]ethyl}benzene-1-sulfonamide (DTEBS) was selected to evaluate glycemia using the glucose tolerance test and insulin secretagogue activity by E.L.I.S.A. The mechanism of action of this compound was studied by 45 Ca2+ influx and whole-cell patch-clamp in rat pancreatic isolated islets. Furthermore, AGE formation in vitro was investigated. We herein show that this novel hybrid compound (DTEBS) exhibits an insulinogenic index and a profile of serum insulin secretion able to maintain glucose homeostasis. Its mechanism of action is mediated by ATP-sensitive potassium channels (KATP) and L-type voltage-dependent calcium channels (VDCC) and by activating protein kinase C and A (PKC and PKA). In addition, the stimulatory action of the compound on calcium influx and insulin secretion indicates that the potentiation of voltage-sensitive K+ currents (Kv) is due to the repolarization phase of the action potential after secretagogue excitation-secretion in pancreatic islets. Furthermore, under these experimental conditions, the compound did not induce toxicity and the in vitro late response of the compound to protein glycation reinforces its use to prevent complications of diabetes. DTEBS exerts an insulin secretagogue effect by triggering KATP, VDCC, and Kv ionic currents, possibly via PKC and PKA pathway signal transduction, in beta-cells. Furthermore, DTEBS may hold potential for delaying the late complications of diabetes.


Subject(s)
Hypoglycemic Agents/pharmacology , Insulin-Secreting Cells/drug effects , Insulin/metabolism , Islets of Langerhans/drug effects , Sulfonylurea Compounds/pharmacology , Animals , Calcium/metabolism , Calcium Channels, L-Type/genetics , Cyclic AMP-Dependent Protein Kinases/genetics , Enzyme-Linked Immunosorbent Assay , Glucose/metabolism , Glucose Tolerance Test , Glyburide/chemistry , Glyburide/pharmacology , Humans , Hypoglycemic Agents/chemical synthesis , Insulin/biosynthesis , Insulin Secretion/drug effects , Islets of Langerhans/metabolism , Islets of Langerhans/pathology , KATP Channels/genetics , Patch-Clamp Techniques , Protein Kinase C/genetics , Rats , Signal Transduction/drug effects , Sulfonylurea Compounds/chemical synthesis , Thiazolidinediones/chemical synthesis , Thiazolidinediones/pharmacology
4.
J Cell Biochem ; 119(6): 4408-4419, 2018 06.
Article in English | MEDLINE | ID: mdl-29130561

ABSTRACT

The aim of the present study was to investigate the mechanism of action of a sulfonamide derivative on glucose uptake in adipose tissue, as well as to characterize the effects of this compound on intestinal disaccharidases and advanced glycation end-products (AGEs) formation. Camphoryl-benzene sulfonamide (CS) was able to stimulate glucose uptake in isolated adipocytes, adipose tissue, and in soleus muscle. The stimulatory effect of the compound (10 µM) on glucose uptake on adipose tissue was blocked by diazoxide, wortmannin, U73122, colchicine, and N-ethylmaleimide. On the other hand, the effects of CS were not blocked by glibenclamide, an inhibitor of the K+ -ATP channel, or even by the inhibitor of protein p38 MAPK, SB 203580. In vivo, this compound reduced intestinal disaccharidase activity, while, in vitro, CS reduced the formation of AGEs at 7, 14, and 28 days of incubation. The stimulatory effect of CS on glucose uptake requires the activation of the K+ -ATP channel, translocation, and fusion of GLUT4 vesicles to the plasma membrane on adipocytes for glucose homeostasis. In addition, the inhibition of disaccharidase activity contributes to the glucose homeostasis in a short-term as well as the remarkable reduction in AGE formation indicates that the CS may prevent of complications of late diabetes.


Subject(s)
Adipocytes/metabolism , Adipose Tissue/metabolism , Cell Membrane/metabolism , Glucose/metabolism , Sulfonamides/pharmacology , Adipocytes/pathology , Adipose Tissue/pathology , Animals , Cell Membrane/pathology , Diabetes Complications/metabolism , Diabetes Complications/pathology , Diabetes Complications/prevention & control , Disaccharides/metabolism , Glycation End Products, Advanced/metabolism , Male , Rats , Rats, Wistar
5.
Artif Organs ; 42(3): 297-304, 2018 Mar.
Article in English | MEDLINE | ID: mdl-29027689

ABSTRACT

Electrochemotherapy (EQT) is a local cancer treatment well established to cutaneous and subcutaneous tumors. Electric fields are applied to biological tissue in order to improve membrane permeability for cytotoxic drugs. This phenomenon is called electroporation or electropermeabilization. Studies have reported that tissue conductivity is electric field dependent. Electroporation numerical models of biological tissues are essential in treatment planning. Tumors of the mouth are very common in dogs. Inadequate EQT treatment of oral tumor may be caused by significant anatomic variations between dogs and tumor position. Numerical models of oral mucosa and tumor allow the treatment planning and optimization of electrodes for each patient. In this work, oral mucosa conductivity during electroporation was characterized by measuring applied voltage and current of ex vivo rats. This electroporation model was used with a spontaneous canine oral melanoma. The model outcomes of oral tumor EQT is applied in different parts of the oral cavity including near bones and the hard palate. The numerical modeling for treatment planning will help the development of new electrodes and increase the EQT effectiveness.


Subject(s)
Dog Diseases/therapy , Electrochemotherapy/methods , Melanoma/veterinary , Mouth Mucosa/pathology , Mouth Neoplasms/veterinary , Animals , Computer Simulation , Dog Diseases/pathology , Dogs , Electric Conductivity , Electrochemotherapy/instrumentation , Electrodes , Electroporation/instrumentation , Electroporation/methods , Equipment Design , Male , Melanoma/pathology , Melanoma/therapy , Models, Biological , Mouth Neoplasms/pathology , Mouth Neoplasms/therapy , Rats, Wistar
6.
Chem Biol Interact ; 279: 95-101, 2018 Jan 05.
Article in English | MEDLINE | ID: mdl-29122539

ABSTRACT

Natural polyacetylene compounds have been found mainly in seven botanical families and remain underexplored and understudied, despite its inherent chemical and biological reactivity, due to the presence of conjugated triple bonds. Some polyacetylene glucosides have been found to stimulate glucose uptake in C5BL/ks-db/db obese diabetic mice, and since polyacetylene glucosides previously found in Vernonia scorpioides showed little to none cytotoxicity, in this study the antihyperglycemic potential of a new V. scorpioides polyacetylene glucoside has been accessed in order to shine a new light on the biological activity of this unique scaffold. For the isolation of this new compound an optimized method of Centrifugal Partition Chromatography (CPC) is for the first time described together with its X-ray data. The results demonstrate that 3,4-dihydrovernoniyne-4-O-ß-glucoside has significant effect on glycaemia at low dose 0.5 mg/kg, and pointing that the anti-hyperglycemic effect may be due in part to the inhibition of intestinal disaccharidases.


Subject(s)
Glucosides/pharmacology , Hypoglycemic Agents/pharmacology , Vernonia/chemistry , Animals , Blood Glucose/drug effects , Glucose , Glucose Tolerance Test , Glucosides/chemistry , Hyperglycemia/chemically induced , Hyperglycemia/drug therapy , Hypoglycemic Agents/chemistry , Male , Models, Molecular , Molecular Structure , Polyynes , Rats , Rats, Wistar
7.
J Ethnopharmacol ; 175: 273-86, 2015 Dec 04.
Article in English | MEDLINE | ID: mdl-26386380

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: The medicinal plant Pterodon pubescens Benth has been traditionally used for a long time to treat rheumatic diseases due to its anti-inflammatory and analgesic activities. The present study aims to evaluate the antinociceptive effect of ethanolic extract from P. pubescens fruits (EEPp) in a model of neuropathic pain in mice. MATERIALS AND METHODS: The phytochemical analysis of EEPp was performed through GC-MS, HPLC and colorimetric analysis. The antinociceptive effects of EEPp (30-300 mg/kg, i.g.) were evaluated on mechanical and thermal (cold or heat) hyperalgesia in neuropathic pain induced by partial sciatic nerve ligation (PSNL) in mice. We also investigated the effects of EEPp on the nociceptive response induced by intrathecal injection (i.t.) of ionotropic (AMPA, NMDA and kainate) and metabotropic (trans-ACPD) glutamate receptor agonists, proinflammatory cytokines such as IL-1ß and TNF-α, as well as TRPV1 and TRPA1 agonists. In addition, we also investigated the safety profile of prolonged treatment with EEPp in mice. RESULTS: The phytochemical analysis showed a higher amount terpenes, being nine sesquiterpenes and seven diterpenes with vouacapan skeletons, as well as a small amount of phenols and flavonoids. The exact mechanism by which EEPp promotes its antinociceptive effect is not yet fully understood, but its oral administration causes significant inhibition of glutamate-, kainate-, NMDA-, trans-ACPD-induced biting responses, as well as of proinflammatory cytokines (TNF-α and IL-1ß) and TRPV1 and TRPA1 channels activators (capsaicin and cinnamaldehyde, respectively). These results may indicate, at least in part, some of the mechanisms that are involved in this effect. In particular, EEPp decreases neuropathic pain and clearly shows, for the first time, a thermal and mechanical hyperalgesia reduction in the model of partial sciatic nerve ligation (PSNL), without inducing tolerance. Furthermore, the prolonged treatment with EEPp (300 mg/kg, i.g.) showed a cumulative effect over 24h, in the 15th day, after last treatment. In addition, the open-field test showed that doses up to 300 mg/kg in both treatments, acute and/or prolonged, did not affect the motor activity of mice. Also, EEPp showed no toxicity according to the serum levels of the renal and hepatic injury indicators or observed macroscopic organs, after PSNL. CONCLUSIONS: Taken together, these results provide the first experimental evidence of the significant antinociceptive effect of EEPp on neuropathic pain without causing side effects, such as sedation or locomotor dysfunction. Moreover, these results appear to be mediated, at least in part, by the inhibition of glutamatergic receptors, TRPV1 and TRPA1 channels and proinflammatory cytokines. Thus, this study adds new scientific evidence and highlights the therapeutic potential of the medicinal plant P. pubescens in the development of phytomedicines for the management of neuropathic pain.


Subject(s)
Analgesics/therapeutic use , Fabaceae , Neuralgia/drug therapy , Plant Extracts/therapeutic use , Analgesics/pharmacology , Animals , Female , Fruit , Hyperalgesia/drug therapy , Hyperalgesia/metabolism , Interleukin-1beta/metabolism , Mice , Neuralgia/metabolism , Phytotherapy , Plant Extracts/pharmacology , Sciatic Nerve/injuries , Spinal Cord Dorsal Horn/drug effects , Spinal Cord Dorsal Horn/metabolism , TRPA1 Cation Channel , TRPV Cation Channels/metabolism , Transient Receptor Potential Channels/metabolism , Tumor Necrosis Factor-alpha/metabolism
8.
An Acad Bras Cienc ; 87(2 Suppl): 1451-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26312423

ABSTRACT

Fructose accumulates in tissue and body fluids of patients affected by hereditary fructose intolerance (HFI), a disorder caused by the deficiency of aldolase B. We investigated the effect of acute fructose administration on the biochemical profile and on the activities of the Krebs cycle enzymes in the cerebral cortex of young rats. Rats received a subcutaneous injection of NaCl (0.9 %; control group) or fructose solution (5 µmol/g; treated group). Twelve or 24 h after the administration, the animals were euthanized and the cerebral cortices were isolated. Peripheral blood (to obtain the serum) and cerebral spinal fluid (CSF) from the animals were also collected. It was observed that albumin levels were decreased and cholesterol levels were increased in CSF of animals 12 h after the administration of fructose. In addition, serum lactate levels were increased 12 h after the administration, as compared to control group. Furthermore, malate dehydrogenase activity was increased in cerebral cortex from treated group 24 h after the administration of this carbohydrate. Herein we demonstrate that fructose administration alters biochemical parameters in CSF and serum and bioenergetics parameters in the cerebral cortex. These findings indicate a possible role of fructose on brain alterations found in HFI patients.


Subject(s)
Cerebral Cortex/drug effects , Fructose Intolerance/metabolism , Fructose/pharmacology , Animals , Cerebral Cortex/metabolism , Disease Models, Animal , Fructose/metabolism , Male , Rats , Rats, Wistar
9.
Rev. bras. farmacogn ; 23(4): 706-715, Aug. 2013. graf, tab
Article in English | LILACS | ID: lil-686646

ABSTRACT

The acute effect of crude extract, n-butanol and aqueous residual fractions of Musa x paradisiaca L., Musaceae, leaves on glycemia, serum insulin secretion and glycogen content in an in vivo approach was evaluated. In addition, the in vitro effect on disaccharidases activity and albumin glycation was studied. The crude extract and fractions, n-butanol and aqueous residual, reduced glycemia and increased liver glycogen content in hyperglycemic rats, inhibited maltase activity and the formation of advanced glycation end-products in vitro. Also, a significant increase in insulin secretion and muscle glycogen content in hyperglycemic rats was observed with oral administration of the n-butanol fraction. Phytochemical analysis demonstrated the presence of rutin in crude extract and fractions of M. x paradisiaca leaves as the major compound. These beneficial effects on the regulation of glucose homeostasis observed for M. x paradisiaca leaves and the presence of rutin as the major compound indicate potential anti-diabetic properties, since previous studies have been reported that rutin can modulate glucose homeostasis.

10.
Eur J Pharmacol ; 702(1-3): 264-8, 2013 Feb 28.
Article in English | MEDLINE | ID: mdl-23399767

ABSTRACT

Rutin is a flavonol glycoside with multiple biological activities and it has been demonstrated that rutin modulates glucose homeostasis. In pancreatic ß-cell, an increase in intracellular calcium concentration triggers exocytosis and thus insulin secretion. The aim of the study reported herein was to investigate the effect of rutin associated intracellular pathways on Ca(2+) uptake in isolated rat pancreatic islets. We focused on the acute effects of rutin on in vivo insulin secretion and the in vitro cellular signaling of pancreatic islets related to this effect. The results show that rutin significantly increased glucose-induced insulin secretion in an in vivo treatment. Moreover, it was demonstrated that rutin stimulated Ca(2+) uptake after 10 min of incubation compared with the respective control group. The involvement of L-type voltage-dependent Ca(2+) channels (L-VDCCs) was evidenced using nifedipine, while the use of glibenclamide and diazoxide demonstrated that the ATP-sensitive potassium (KATP) channels are not involved in the rutin action in pancreatic islets. In conclusion, rutin diminish glycemia, potentiate insulin secretion in vivo and significantly stimulates Ca(2+) uptake in rat pancreatic islets. A novel cellular mechanism of action of rutin in Ca(2+) uptake on pancreatic ß-cells was elucidated. Rutin modulates Ca(2+) uptake in pancreatic islets by opening L-VDCCs, alter intracellular Ca(2+), PLC and PKC signaling pathways, characterizing KATP channel-independent pathways. These findings highlight rutin, a dietary adjuvant, as a potential insulin secretagogue contributing to glucose homeostasis.


Subject(s)
Calcium/metabolism , Hyperglycemia/metabolism , Hypoglycemic Agents/pharmacology , Insulin/blood , Islets of Langerhans/metabolism , Rutin/pharmacology , Animals , Blood Glucose/analysis , Cells, Cultured , Hyperglycemia/drug therapy , Hypoglycemic Agents/therapeutic use , Male , Rats , Rats, Wistar , Rutin/therapeutic use , Signal Transduction/drug effects
11.
Molecules ; 17(6): 6754-68, 2012 Jun 04.
Article in English | MEDLINE | ID: mdl-22664465

ABSTRACT

In this study, the in vivo effect of the crude extract and n-butanol and aqueous residual fractions of Baccharis articulata (Lam.) Pers. on serum glucose levels, insulin secretion and liver and muscle glycogen content, as well as in vitro action on serum intestinal disaccharidase activity and albumin glycation were investigated. Oral administration of the extract and fractions reduced glycemia in hyperglycemic rats. Additionally, the n-butanol fraction, which has high flavonoids content, stimulated insulin secretion, exhibiting an insulinogenic index similar to that of glipizide. Also, the n-butanol fraction treatment significantly increased glycogen content in both liver and muscle tissue. In vitro incubation with the crude extract and n-butanol and aqueous residual fractions inhibited maltase activity and the formation of advanced glycation end-products (AGEs). Thus, the results demonstrated that B. articulata exhibits a significant antihyperglycemic and insulin-secretagogue role. These effects on the regulation of glucose homeostasis observed for B. articulata indicate potential anti-diabetic properties.


Subject(s)
Baccharis/chemistry , Glucose/metabolism , Hypoglycemic Agents/pharmacology , Plant Extracts/pharmacology , 1-Butanol/chemistry , Animals , Blood Glucose/drug effects , Diabetes Mellitus, Experimental/metabolism , Flavonoids/chemistry , Glucose Tolerance Test , Glycation End Products, Advanced , Glycogen/metabolism , Glycoside Hydrolase Inhibitors , Glycosylation/drug effects , Homeostasis/drug effects , Hypoglycemic Agents/chemistry , Insulin/blood , Insulin/metabolism , Insulin Secretion , Male , Phenols/chemistry , Plant Extracts/chemistry , Rats , Rats, Wistar , Serum Albumin , Time , Time Factors , Glycated Serum Albumin
12.
Reprod Fertil Dev ; 23(5): 725-35, 2011.
Article in English | MEDLINE | ID: mdl-21635821

ABSTRACT

It is well known that the vitamin D endocrine system is involved in physiological and biochemical events in numerous tissues, especially gut, bone and kidney but also testis. Therefore, in this study the effect and mechanisms of action of 1α,25(OH)(2) vitamin D(3) (1,25D) on aromatase gene expression in immature rat Sertoli cells were evaluated. Vitamin D receptor transcripts were present in immature Sertoli cells as well as in adult testicular germ cells and somatic cells. The treatment of immature Sertoli cells with 100 nM 1,25D increased the amount of aromatase transcript, mainly in 30-day-old rats. The protein kinase A (PKA) blocker, H89, partially inhibited the 1,25D effect. The stimulation of aromatase gene expression in 30-day-old Sertoli cells by the agonist 1α,25(OH)(2) lumisterol(3), and the suppression of the 1,25D effect by the antagonists 1ß,25(OH)(2) vitamin D(3) and (23S)-25-dehydro-1α (OH)-vitamin D(3)-26,23-lactone suggested, besides a genomic effect of 1,25D, the existence of non-genomic activation of the membrane-bound vitamin D receptor involving the PKA pathway.


Subject(s)
Aromatase/metabolism , Calcitriol/metabolism , Sertoli Cells/enzymology , Age Factors , Animals , Aromatase/genetics , Calcitriol/analogs & derivatives , Calcitriol/pharmacology , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Cyclic AMP-Dependent Protein Kinases/metabolism , Ergosterol/pharmacology , Gene Expression Regulation, Enzymologic , Isoquinolines/pharmacology , Male , Protein Kinase Inhibitors/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Calcitriol/antagonists & inhibitors , Receptors, Calcitriol/genetics , Receptors, Calcitriol/metabolism , Sertoli Cells/drug effects , Sulfonamides/pharmacology
13.
IEEE Trans Biomed Eng ; 58(12): 3310-8, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21193368

ABSTRACT

An intense electric field can be applied to increase the membrane conductance G(m) and consequently, the conductivity of cell suspension. This phenomenon is called electroporation. This mechanism is used in a wide range of medical applications, genetic engineering, and therapies. Conductivity measurements of cell suspensions were carried out during application of electric fields from 40 to 165 kV/m. Experimental results were analyzed with two electroporation models: the asymptotic electroporation model was used to estimate G(m) at the beginning and at the end of electric field pulse, and the extended Kinosita electroporation model to increase G(m) linearly in time. The maximum G(m) was 1-7 × 10(4) S/m(2), and the critical angle (when the G(m) is insignificant) was 50°-65°. In addition, the sensitivity of electroporated membrane conductance to extracellular and cytoplasmatic conductivity and cell radius has been studied. This study showed that external conductivity and cell radius are important parameters affecting the pore-opening phenomenon. However, if the cell radius is larger than 7 µm in low conductivity medium, the cell dimensions are not so important.


Subject(s)
Cell Physiological Phenomena , Electroporation/methods , Membrane Potentials/physiology , Models, Biological , Animals , Cell Membrane/physiology , Electric Conductivity , Electromagnetic Fields , Erythrocytes/physiology , Male , Porosity , Rats , Rats, Wistar
14.
J Steroid Biochem Mol Biol ; 119(3-5): 127-34, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20156558

ABSTRACT

Sertoli cell secretory activities are highly dependent on ion channel functions and critical to spermatogenesis. The steroid hormone 1alpha,25(OH)2-vitamin D3 (1,25(OH)2-D3) stimulates exocytosis in different cell systems by activating a nongenotropic vitamin D receptor (VDR). Here, we described 1,25(OH)2-D3 stimulation of secretion via Cl(-) channel activation in the mouse immature Sertoli cell line TM4. 1,25(OH)2-D3 potentiation of chloride currents was dependent on hormone concentration, and correlated with a significant increase in whole-cell capacitance within 20-40 min. In addition, Cl(-) currents were potentiated by the nongenomic VDR agonist 1alpha,25(OH)2 lumisterol D3 (JN), while 1,25(OH)2-D3 potentiation of channels was suppressed by nongenomic VDR antagonist 1beta,25(OH)2-vitamin D3 (HL). Treatment of TM4 cells with PKC and PKA activators PMA and forskolin respectively, increased Cl(-) currents significantly, while PKC and PKA inhibitors Go6983 and H-89, respectively, abolished 1,25(OH)2-D3 stimulation of Cl(-) currents, suggesting phosphorylation pathways in 1,25(OH))2-D3 mediated channel responses. RT-PCR demonstrated the expression of outwardly rectifying ClC-3 channels in TM4 cells. Taken together, our results demonstrate a PKA/PKC-dependent 1,25(OH)2-D3/VDR nongenotropic pathway leading to Cl(-) channel and exocytosis activation in Sertoli cells. We conclude that 1,25(OH)2-D3 appears to be a modulator of male reproductive functions at least in part by stimulating Sertoli cell secretory functions.


Subject(s)
Calcitriol/pharmacology , Chloride Channels/metabolism , Sertoli Cells/drug effects , Sertoli Cells/metabolism , Adenylyl Cyclases/metabolism , Animals , Calcifediol/pharmacology , Calcitriol/analogs & derivatives , Calcitriol/metabolism , Cell Line , Cell Membrane/drug effects , Cell Membrane/metabolism , Chloride Channels/antagonists & inhibitors , Chloride Channels/genetics , Cyclic AMP/agonists , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Cyclic AMP-Dependent Protein Kinases/metabolism , Dose-Response Relationship, Drug , Enzyme Activators/pharmacology , Exocytosis/drug effects , Gene Expression , Ion Channel Gating/drug effects , Male , Mice , Protein Isoforms/antagonists & inhibitors , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/metabolism , RNA, Messenger/metabolism , Receptors, Calcitriol/agonists , Receptors, Calcitriol/antagonists & inhibitors , Receptors, Calcitriol/genetics , Receptors, Calcitriol/metabolism , Sertoli Cells/pathology
15.
Steroids ; 74(2): 264-9, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19073199

ABSTRACT

1,25D3 is critical for the maintenance of normal reproduction since reduced fertility is observed in male rats on a vitamin D-deficient diet. Vitamin D-deficient male rats have incomplete spermatogenesis and degenerative testicular changes. In the present study we have examined the ionic involvement and intracellular messengers of the stimulatory effect of 1,25D3 on amino acid accumulation in immature rat testis. 1,25D3 stimulates amino acid accumulation from 10(-12) to 10(-6) M by increasing the slope to reach a maximum value at 10(-10) M, as compared to the control group. No effect was observed at a lower dose (10(-13) M). Time-course showed an increase on amino acid accumulation after 15, 30, and 60 min of incubation with 1,25D3 (10(-10) M). 1,25D3 stimulated amino acid accumulation in 11-day-old rat testis but not in testis that were 20 days old. Cycloheximide totally blocked the 1,25D3 action on amino acid accumulation. Furthermore, a localized elevation of cAMP increased the stimulatory effect of 1,25D3 and the blockage of PKA nullified the action of the hormone. In addition, 1,25D3 action on amino acid accumulation was also mediated by ionic pathways, since verapamil and apamine diminished the hormone effect. The stimulatory effect of 1,25D3 on amino acid accumulation is age-dependent and specific to this steroidal hormone since testosterone was not able to change amino acid accumulation in both ages studied. This study provides evidence for a dual effect for 1,25D3, pointing to a genomic effect that can be triggered by PKA, as well as to a rapid response involving Ca2+/K+ channels on the plasma membrane.


Subject(s)
Calcitriol/pharmacology , Testis/drug effects , Testis/metabolism , beta-Alanine/analogs & derivatives , Age Factors , Animals , Bucladesine/metabolism , Carbazoles/pharmacology , Carbon Radioisotopes/chemistry , Dose-Response Relationship, Drug , Intracellular Space/drug effects , Intracellular Space/metabolism , Ion Channels/metabolism , Male , Protein Biosynthesis , Pyrroles/pharmacology , Rats , Rats, Wistar , Testis/growth & development , Testosterone/pharmacology , Time Factors , beta-Alanine/chemistry , beta-Alanine/metabolism
16.
J Nat Prod ; 71(4): 532-5, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18303854

ABSTRACT

A stimulatory effect of kaempferol 3-neohesperidoside ( 1) on glucose uptake (35% and 21%) was observed when the rat soleus muscle was incubated with 1 and 100 nM of this flavonoid glycoside, respectively. The concentration-response curve of insulin showed a stimulatory effect at 3.5 and 7.0 nM (42% and 50%) on glucose uptake when compared with the control group. The effect of 1 on glucose uptake was completely nullified by pretreatment with LY294002, an inhibitor of phosphoinositide 3-kinase (PI3K), and RO318220, an inhibitor of protein kinase C (PKC). However, no significant change occurred on glucose uptake stimulated by 1 when muscles were pretreated with PD98059, an inhibitor of mitogen-activated protein kinase (MEK), and cycloheximide, an inhibitor of protein synthesis. Compound 1 and insulin (7 nM) did not show a synergistic effect on glucose uptake. Additionally, 100 mg/kg of 1 by oral gavage was able to increase glycogen content in the muscle. These results suggest that 1 stimulates glucose uptake in the rat soleus muscle via the PI3K and PKC pathways and, at least in part, independently of MEK pathways and the synthesis of new glucose transporters.


Subject(s)
Blood Glucose/analysis , Diabetes Mellitus, Experimental/drug therapy , Ferns/chemistry , Insulin/pharmacology , Kaempferols/pharmacology , Muscle, Skeletal/drug effects , Plants, Medicinal/metabolism , Alloxan/pharmacology , Animals , Blood Glucose/drug effects , Disease Models, Animal , Glycogen/analysis , Molecular Structure , Rats
17.
Cell Mol Neurobiol ; 26(2): 209-24, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16763783

ABSTRACT

: Thyroid hormones play important roles in brain function. However, few information is available about the effect of 3,5,3'-triiodo-L-thyronine (T(3)) or thyroxine (T(4)) on the in vitro phosphorylation of intermediate filament (IF) proteins from cerebral cortex of rats. In this study we investigated the involvement of GABAergic mechanisms mediating the effects of T(3) and T(4) on the in vitro incorporation of (32)P into IF proteins from cerebral cortex of 10-day-old male rats. Tissue slices were incubated with or without T(3), T(4), gamma-aminobutiric acid (GABA), kinase inhibitors or specific GABA antagonists and (32)P-orthophosphate for 30 min. The IF-enriched cytoskeletal fraction was extracted in a high salt Triton-containing buffer and the in vitro (32)P incorporation into IF proteins was measured. We first observed that 1 microM T(3) and 0.1 microM T(4) significantly increased the in vitro incorporation of (32)P into the IF proteins studied through the PKA and PKCaMII activities. A similar effect on IF phosphorylation was achieved by incubating cortical slices with GABA. Furthermore, by using specific GABA antagonists, we verified that T(3) induced a stimulatory effect on IF phosphorylation through noncompetitive mechanisms involving GABA(A), beyond GABA(B) receptors. In contrast, T(4) effects were mediated mainly by GABA(B) mechanisms. In conclusion, our results demonstrate a rapid nongenomic action of T(3) and T(4) on the phosphorylating system associated to the IF proteins in slices of cerebral cortex of 10 day-old male rats and point to GABAergic mechanisms mediating such effects.


Subject(s)
Cerebral Cortex/drug effects , Cytoskeletal Proteins/metabolism , Cytoskeleton/drug effects , Intermediate Filaments/metabolism , Thyroxine/pharmacology , Triiodothyronine/pharmacology , gamma-Aminobutyric Acid/metabolism , Animals , Cerebral Cortex/cytology , Cerebral Cortex/metabolism , Cytoskeleton/metabolism , Male , Protein Subunits/metabolism , Rats , Rats, Wistar
18.
Eur J Endocrinol ; 147(3): 425-33, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12213681

ABSTRACT

The importance of non-genomic signaling as a complementary route for cell regulation has recently become evident. This rapid mechanism is utilized not just by peptide hormones, but also by steroids and other lipid-related substances, resulting in amplification and fine-tuning of the signals. The Sertoli cell is the principal target for hormone action in the seminiferous tubules. The involvement of FSH, testosterone and tri-iodothyronine (T(3)) in the spermatogenetic process is widely known. This paper discusses some rapid responses to FSH, retinol, testosterone and T(3) in the control of Sertoli cell function. Studies employing various methodologies and techniques are described and several hypotheses are considered in an attempt to explain the interactions of hormones with plasma membrane receptors. Recent knowledge about these new signaling mechanisms and cross-talk between them opens new fields of research on the communication and integration of the multiple hormonal signaling systems.


Subject(s)
Sertoli Cells/metabolism , Signal Transduction , Animals , Calcitriol/physiology , Follicle Stimulating Hormone/physiology , Humans , Male , Testosterone/physiology , Triiodothyronine/physiology , Vitamin A/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...